MiR-135b-5p is an oncogene in pancreatic cancer to regulate GPRC5A expression by targeting transcription factor KLF4

[1]  Lynette M. Smith,et al.  Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness , 2020, Cancer Research.

[2]  Zhan Shen,et al.  miR-152-3p Affects the Progression of Colon Cancer via the KLF4/IFITM3 Axis , 2020, Comput. Math. Methods Medicine.

[3]  G. Daley,et al.  Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target , 2020, Nature Communications.

[4]  Gang Chen,et al.  miR-939-5p Contributes to the Migration and Invasion of Pancreatic Cancer by Targeting ARHGAP4 , 2020, OncoTargets and therapy.

[5]  Fan Zhang,et al.  miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2 , 2019, Journal of experimental & clinical cancer research : CR.

[6]  Jennifer A. Mitchell,et al.  KLF4 protein stability regulated by interaction with pluripotency transcription factors overrides transcriptional control , 2019, bioRxiv.

[7]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[8]  X. Li,et al.  KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer , 2018, Cell Communication and Signaling.

[9]  Yuan Yin,et al.  Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1 , 2018, Cellular Physiology and Biochemistry.

[10]  Wen-xian Hu,et al.  The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth , 2018, Cell Death & Disease.

[11]  X. Niu,et al.  Integrated analysis of microRNA and mRNA expression profiles in rats with selenium deficiency and identification of associated miRNA-mRNA network , 2018, Scientific Reports.

[12]  Chen Huang,et al.  Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression , 2018, Cellular Physiology and Biochemistry.

[13]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[14]  Miao Chen,et al.  KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer. , 2018, Cellular signalling.

[15]  Yanqing Wang,et al.  Imbalance of a KLF4-miR-7 auto-regulatory feedback loop promotes prostate cancer cell growth by impairing microRNA processing. , 2018, American journal of cancer research.

[16]  X. Che,et al.  miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  Wei Shi,et al.  KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling. , 2017, Oncology reports.

[18]  H. Saiyin,et al.  Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancer. , 2017, Oncotarget.

[19]  B. Ryan.  microRNAs in Cancer Susceptibility , 2017, Advances in cancer research.

[20]  Lu Yang,et al.  GPRC5A exerts its tumor-suppressive effects in breast cancer cells by inhibiting EGFR and its downstream pathway. , 2016, Oncology reports.

[21]  K. Xie,et al.  The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer , 2016, Clinical Cancer Research.

[22]  Wenlin Huang,et al.  KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth , 2016, Oncotarget.

[23]  Suyun Huang,et al.  KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis. , 2016, Cancer research.

[24]  J. Ruppert,et al.  Kruppel-like Pluripotency Factors as Modulators of Cancer Cell Therapeutic Responses. , 2016, Cancer research.

[25]  Subrata Sen,et al.  MicroRNA as Biomarkers and Diagnostics , 2016, Journal of cellular physiology.

[26]  Rong-jiang Wang,et al.  miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6 , 2015, Oncology letters.

[27]  L. Ricci-Vitiani,et al.  miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal , 2015, Oncotarget.

[28]  Chin-Wen Chi,et al.  Krüppel-like factor 4 modulates the migration and invasion of hepatoma cells by suppressing TIMP-1 and TIMP-2. , 2015, Oncology reports.

[29]  Jun Zhang,et al.  A Novel KLF4/LDHA Signaling Pathway Regulates Aerobic Glycolysis in and Progression of Pancreatic Cancer , 2014, Clinical Cancer Research.

[30]  A. Adai,et al.  Global microRNA expression profiling of microdissected tissues identifies miR‐135b as a novel biomarker for pancreatic ductal adenocarcinoma , 2012, International journal of cancer.

[31]  Qiang Li,et al.  KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis , 2011, Clinical Cancer Research.

[32]  Fang Yu,et al.  Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion , 2010, Oncogene.

[33]  X. Le,et al.  Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. , 2008, Cancer research.

[34]  R. DePinho,et al.  Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.

[35]  K. Xie,et al.  Emerging role of KLF4 in human gastrointestinal cancer. , 2006, Carcinogenesis.